Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
46.98
+1.49 (3.28%)
At close: Aug 10, 2026, 4:00 PM EDT
46.98
0.00 (0.00%)
After-hours: Aug 10, 2026, 4:10 PM EDT
Rapport Therapeutics Employees
Rapport Therapeutics had 84 employees as of December 31, 2025. The number of employees increased by 15 or 21.74% compared to the previous year.
Employees
84
Change (1Y)
15
Growth (1Y)
21.74%
Revenue / Employee
$238,095
Profits / Employee
-$1,632,857
Market Cap
2.25B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 84 | 15 | 21.74% |
| Dec 31, 2024 | 69 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| AbCellera Biologics | 562 |
| UroGen Pharma | 298 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
| Taysha Gene Therapies | 99 |
RAPP News
- 5 days ago - Rapport Therapeutics reports Q2 EPS ($1.19), consensus (99c) - TheFly
- 5 days ago - Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update - GlobeNewsWire
- 5 days ago - Rapport Therapeutics Earnings release: Q2 2026 - Filings
- 5 days ago - Rapport Therapeutics Quarterly report: Q2 2026 - Filings
- 5 days ago - Rapport Therapeutics Slides: Corporate presentation - Filings
- 13 days ago - Rapport Therapeutics initiated with an Outperform at William Blair - TheFly
- 26 days ago - Rapport Therapeutics management to meet with Citizens - TheFly
- 5 weeks ago - Rapport Therapeutics Slides: Corporate presentation - Filings